Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kenvue Inc. Common Stock
(NY:
KVUE
)
22.89
-0.29 (-1.23%)
Streaming Delayed Price
Updated: 12:01 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kenvue Inc. Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE
September 25, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
3 Best Stocks to Buy in September and Hold Forever
September 24, 2023
Healthcare blue chip stocks with proven track records can be excellent long-term investments.
Via
The Motley Fool
3 Reasons SharkNinja Is Swimming Toward New Highs
September 22, 2023
Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders.
Via
MarketBeat
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
September 22, 2023
From
Kenvue Inc.
Via
Business Wire
Check Out What Whales Are Doing With KVUE
September 19, 2023
Via
Benzinga
Looking Into Kenvue's Recent Short Interest
September 18, 2023
Via
Benzinga
Kenvue Unusual Options Activity For September 13
September 13, 2023
Via
Benzinga
Better Buy: J&J vs. Kenvue
September 13, 2023
You can count on both of these companies for passive income, too.
Via
The Motley Fool
KVUE INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation – KVUE
September 21, 2023
From
Rosen Law Firm
Via
Business Wire
2 Incredibly Cheap Dividend Stocks to Buy Now
September 20, 2023
High-quality dividend stocks are rarely cheap. These two names are an exception.
Via
The Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
September 19, 2023
Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape.
Via
InvestorPlace
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income
September 17, 2023
These companies generate durable and growing cash flows.
Via
The Motley Fool
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year
September 15, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money.
Via
Benzinga
Analyst Ratings for Kenvue
September 11, 2023
Via
Benzinga
Kenvue Unusual Options Activity
September 07, 2023
Via
Benzinga
Is J&J a Buy After the Kenvue Separation?
September 06, 2023
J&J shares have been on the decline.
Via
The Motley Fool
3 Great Dividend Stocks You Can Buy for Less Than $50
September 15, 2023
These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.
Via
The Motley Fool
3 Blue-Chip Stocks to Watch in the ‘Green Zone’
September 14, 2023
Now may be the time to take a look at these three blue-chips, as each one is currently in the "Green Zone stocks" category.
Via
InvestorPlace
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023
September 11, 2023
Via
Benzinga
Kenvue Unusual Options Activity For September 01
September 01, 2023
Via
Benzinga
Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip
September 10, 2023
The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
The 7 Best Dow Stocks to Buy Now: September 2023
September 08, 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
September 07, 2023
Via
Benzinga
J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block
September 07, 2023
Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion.
Via
MarketBeat
Topics
ETFs
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
September 07, 2023
The recently spun-off Kenvue looks to be a high-quality dividend stock.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users?
Via
Benzinga
Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation
September 05, 2023
Johnson & Johnson (NYSE: JNJ) is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc (NYSE: KVUE) to bolster its growth in
Via
Benzinga
Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?
September 02, 2023
Johnson & Johnson has completed its separation of Kenvue.
Via
The Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.